These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22524450)

  • 1. Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening.
    Lavecchia A; Di Giovanni C; Pesapane A; Montuori N; Ragno P; Martucci NM; Masullo M; De Vendittis E; Novellino E
    J Med Chem; 2012 May; 55(9):4142-58. PubMed ID: 22524450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
    Park H; Li M; Choi J; Cho H; Ham SW
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-based virtual ligand screening for the identification of novel CDC25 phosphatase inhibitors.
    Montes M; Braud E; Miteva MA; Goddard ML; Mondésert O; Kolb S; Brun MP; Ducommun B; Garbay C; Villoutreix BO
    J Chem Inf Model; 2008 Jan; 48(1):157-65. PubMed ID: 18154280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: effect of dimerisation on phosphatase inhibition.
    Sarkis M; Tran DN; Kolb S; Miteva MA; Villoutreix BO; Garbay C; Braud E
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7345-50. PubMed ID: 23141909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The design of novel inhibitors for treating cancer by targeting CDC25B through disruption of CDC25B-CDK2/Cyclin A interaction using computational approaches.
    Li HL; Ma Y; Ma Y; Li Y; Chen XB; Dong WL; Wang RL
    Oncotarget; 2017 May; 8(20):33225-33240. PubMed ID: 28402259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors.
    Kolb S; Mondésert O; Goddard ML; Jullien D; Villoutreix BO; Ducommun B; Garbay C; Braud E
    ChemMedChem; 2009 Apr; 4(4):633-48. PubMed ID: 19212959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel Cdc25 phosphatase inhibitors with micromolar activity based on the structure-based virtual screening.
    Park H; Bahn YJ; Jung SK; Jeong DG; Lee SH; Seo I; Yoon TS; Kim SJ; Ryu SE
    J Med Chem; 2008 Sep; 51(18):5533-41. PubMed ID: 18714978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity.
    Brun MP; Braud E; Angotti D; Mondésert O; Quaranta M; Montes M; Miteva M; Gresh N; Ducommun B; Garbay C
    Bioorg Med Chem; 2005 Aug; 13(16):4871-9. PubMed ID: 15921913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and characterization of a novel inhibitor of CDC25B, LGH00045.
    Feng X; Wang LN; Zhou YY; Yu HP; Shen Q; Zang Y; Zhou YB; Li JY; Zhang HX; Li J
    Acta Pharmacol Sin; 2008 Oct; 29(10):1268-74. PubMed ID: 18817634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of 3-aminoisoquinolin-1(2H)-one based inhibitors of the dual-specificity phosphatase Cdc25B.
    George Rosenker KM; Paquette WD; Johnston PA; Sharlow ER; Vogt A; Bakan A; Lazo JS; Wipf P
    Bioorg Med Chem; 2015 Jun; 23(12):2810-8. PubMed ID: 25703307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties.
    Braud E; Goddard ML; Kolb S; Brun MP; Mondésert O; Quaranta M; Gresh N; Ducommun B; Garbay C
    Bioorg Med Chem; 2008 Oct; 16(19):9040-9. PubMed ID: 18789703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.
    Johnston PA; Foster CA; Tierno MB; Shun TY; Shinde SN; Paquette WD; Brummond KM; Wipf P; Lazo JS
    Assay Drug Dev Technol; 2009 Jun; 7(3):250-65. PubMed ID: 19530895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design novel inhibitors for treating cancer by targeting Cdc25B catalytic domain with de novo design.
    Wu JW; Zhang H; Duan YQ; Dong WL; Cheng XC; Wang SQ; Wang RL
    Comb Chem High Throughput Screen; 2014; 17(10):837-47. PubMed ID: 25360618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and characterization of novel small molecule inhibitors of human Cdc25B dual specificity phosphatase.
    Brisson M; Nguyen T; Vogt A; Yalowich J; Giorgianni A; Tobi D; Bahar I; Stephenson CR; Wipf P; Lazo JS
    Mol Pharmacol; 2004 Oct; 66(4):824-33. PubMed ID: 15231869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.
    Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL
    Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review.
    Lavecchia A; Di Giovanni C; Novellino E
    Expert Opin Ther Pat; 2010 Mar; 20(3):405-25. PubMed ID: 20166845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases.
    Valente S; Bana E; Viry E; Bagrel D; Kirsch G
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5827-30. PubMed ID: 20800482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Cdc25 phosphatases by indolyldihydroxyquinones.
    Sohn J; Kiburz B; Li Z; Deng L; Safi A; Pirrung MC; Rudolph J
    J Med Chem; 2003 Jun; 46(13):2580-8. PubMed ID: 12801222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors.
    Park H; Bahn YJ; Ryu SE
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4330-4. PubMed ID: 19497739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule inhibitors of dual specificity protein phosphatases.
    Pestell KE; Ducruet AP; Wipf P; Lazo JS
    Oncogene; 2000 Dec; 19(56):6607-12. PubMed ID: 11426646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.